Medscape

Intra-Aortic Balloon Counterpulsation as a Bridge to Heart Transplantation Does Not Impair Long-Term Survival

Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and haemodynamic ...
Forbes

ESC: Trial Finds No Benefit For Intraaortic Balloon Counterpulsation In Cardiogenic Shock

Despite a lack of evidence, circulatory support with intraaortic balloon counterpulation (IABP) has a class 1 recommendation in the guidelines and is often used in patients in cardiogenic shock ...
TCTMD

Maquet Announces Peer-Reviewed Publication Showing Larger Capacity Intra-aortic Balloon Pumps to have Greater Hemodynamic Effect on Patients

WAYNE, N.J., Maquet Getinge Group announced today the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps ...
Healio

CRISP AMI: Intra-aortic balloon pump counterpulsation failed to reduce infarct size in STEMI patients

Please provide your email address to receive an email when new articles are posted on . Infarct size as measured by MRI does not reduce when intra-aortic balloon pump counterpulsation is used before ...
TCTMD

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...
Forbes

No Benefit for Routine Counterpulsation Found in CRISP AMI

Routine use of intra-aortic balloon counterpulsation (IABC) in STEMI patients who do not have cardiogenic shock does not reduce infarct size, according to a new trial. Results from the CRISP AMI ...
FiercePharma

--Study Results Demonstrating Trend Toward Improvement in 30-Day All-Cause Mortality Presented at ESC Congress 2012-

MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Nature

Intra-aortic balloon support for MI and cardiogenic shock—time to change the guidelines?

The results of the Intraaortic Balloon Pump in Cardiogenic Shock (IABP-SHOCK) II trial, presented at the 2012 European Society of Cardiology Congress and published in the New England Journal of ...
Healio

Intra-aortic balloon counterpulsation failed to reduce MI size in patients with acute anterior MI without shock

Please provide your email address to receive an email when new articles are posted on . A routine strategy of intra-aortic balloon counterpulsation before percutaneous coronary intervention did not ...
The New England Journal of Medicine

Intraaortic Balloon Support for Cardiogenic Shock

To the Editor: In the study by Thiele et al. (Oct. 4 issue) 1 on the use of intraaortic balloon counterpulsation (IABP) in patients with cardiogenic shock caused by acute myocardial infarction, the ...
Medscape

Intra-Aortic Balloon Counterpulsation as a Bridge to Heart Transplantation Does Not Impair Long-Term Survival

This study demonstrates that IABP is a valuable tool as a bridge to HTx in patients with end-stage heart failure. Kaplan–Meier analysis revealed no significant difference in post-HTx survival between ...